Director, Medical Science Liaison, Carolinas

Responsibilities

• Identify and cultivate professional relationships KOLs in designated tumor types.
• Maintain cross-functional field partnerships allowing for appropriate collaboration with field commercial teams (sales, market access, etc.), and Clinical Development associates.
• Maintain and develop synergistic relationships with KOLs to expand research, advisory, and educational partnership opportunities.
• Aid the Clinical Development Team in the identification and education of potential clinical trial sites, assist, upon request, in troubleshooting issues during clinical trial conduct.
• Develop scientific expertise on all Celcuity’s products, related disease states, and the clinical practice for a given therapeutic area.
• Communicate scientific content, written and verbal, related to Celcuity’s products and related disease states.
• Be knowledgeable of and follow all applicable laws, SOPs and guidance documents ensuring compliance.
• Provide scientific training to internal colleagues.
• Participate in the Medical, Legal, and Regulatory review process, as needed, in the role of scientific expert.
• Identify, categorize, and communicate key clinical insights related to assigned disease state and products.

Qualifications

• MD, PharmD, or PhD in Life Sciences, D.Sc., D.N.P, or D.O. degree
• Solid tumor oncology experience
• Excellent presentation and communication skills
• Conveying complex scientific concepts and information appropriately tailored to the audience (internal staff, physicians, nurses, patient advocacy groups, formulary committees, etc.)
• 3+ years of related pharmaceutical Medical Science Liaison experience
• Breast Cancer experience
• Knowledge of clinical research design and GCP in the oncology area
• Experiences at small / start-up biopharmaceutical company
• Strong business acumen
• Experience with payor groups, market access teams, formulary committees, and treatment guidelines
• Experience managing territory resources and budgets
• Demonstrated self-starter

About Us

Celcuity is a clinical-stage, publicly traded biotechnology company seeking to extend the lives of cancer patients through the development of targeted therapies for the treatment of multiple solid tumor indications. The company was founded to develop a better way to treat the cellular drivers of tumor growth. Our lead therapeutic candidate, gedatolisib, is an intravenously administered, potential first-in-class PI3K/AKT/mTOR (PAM) pathway inhibitor. Its mechanism of action and pharmacokinetic properties are highly differentiated from other currently approved and investigational therapies that target PI3K or mTOR alone or together. Gedatolisib phase 3 clinical development programs are focused on the treatment of patients with HR+/HER2- ABC in the 1L and 2L settings. A Phase 1b/2 clinical trial evaluating gedatolisib in combination with darolutamide in patients with metastatic castration resistant prostate cancer, is on-going. Celcuity Is An Equal-Opportunity Employer

Pay & Schedule

The anticipated base pay range is $230,000-$275,000 DOE. The exact base pay offered for this role will depend on various factors, including but not limited to the candidate’s geography, qualifications, skills, and experience. The successful candidate will be eligible for an annual performance incentive bonus and a new hire equity package. Celcuity also offers various benefits offerings, including, but not limited to, medical, dental, vision insurance, 401(k) match, PTO, and paid holidays.